R&D Systems™ Human IL-19 Recombinant Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Supplier:  R&D Systems™ 1035IL025

Catalog No. 1035IL025

Description

The Recombinant Human IL-19 Protein is derived from E. coli. The Recombinant Human IL-19 Protein has been validated for the following applications: Bioactivity.

Specifications

• Formulation: Lyophilized from a 0.2μm filtered solution in PBS with BSA as a carrier protein.
• Molecular Weight (g/mol): 18 kDa (monomer)
• Quantity: 25μg
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Recombinant: Recombinant
• Purity or Quality Grade: >97%, by SDS-PAGE under reducing conditions and visualized by silver stain.

• Gene ID (Entrez): 29949
• Name: IL-19
• Source: E. coli-derived human IL-19 protein Leu25-Ala177,with an N-terminal Met
• Conjugate: Unconjugated
• Reconstitution: Reconstitute at 100μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin.